AI assistant
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2014
Apr 1, 2014
30583_dirs_2014-04-01_353ada78-1de1-4b7d-9828-4dbc032ea20a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2014-03-28
Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-03-28 | Common Stock | M | 2000 | $12.99 | Acquired | 48740 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-03-28 | Stock Option (right to buy Common Stock) | $12.99 | M | 2000 | Disposed | 2016-05-10 | Common Stock (2000) | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 194520 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy Common Stock) | $12.99 | 2016-05-10 | Common Stock (10000) | 10000 | Indirect |
| Stock Option (right to buy Common Stock) | $12.99 | 2016-05-10 | Common Stock (10000) | 10000 | Indirect |
| Stock Option (right to buy Common Stock) | $12.99 | 2016-05-10 | Common Stock (10000) | 10000 | Indirect |
| Stock Option (right to buy Common Stock) | $12.99 | 2016-05-10 | Common Stock (10000) | 10000 | Indirect |
| Stock Option (right to buy Common Stock) | $12.99 | 2016-05-10 | Common Stock (20000) | 20000 | Indirect |
Footnotes
F1: The reporting person and his spouse act as trustees for the Bienaime Family Trust.
F2: Form 4s filed by the reporting person between March 4, 2013 and February 24, 2014 (the "Prior Forms 4s") inadvertently reported as common stock indirectly owned by the reporting person on Table I options to purchase an aggregate of 60,000 shares held in trusts for the reporting person's children (the "Options") while certain of the Prior Form 4s inadvertently omitted the Options from Table II. The reporting person gifted the Options to his children's trusts on October 19, 2012 and the transactions were reported on the Form 5 filed by the reporting person on February 14, 2013. As the Options have not been exercised and remain derivative securities indirectly owned by the reporting person, the Options should not have been included in Table I in the Prior Form 4s and have been correctly listed as derivative securities on Table II of this Form 4.
F3: The reporting person's spouse is trustee of each child's trust.